SCHEMBL5823577

SCHEMBL5823577

CCc1cc(Nc2cc(C)nc(Cl)n2)n[nH]1.Cc1cc(Cl)nc(Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 13/20 0.41
AURKA O14965 5/20 0.41
PAK4 O96013 2/20 0.40
PLK4 O00444 1/20 0.40
IGF1R P08069 6/20 0.37
NTRK1 P04629 2/20 0.37
FGFR1 P11362 2/20 0.36
KDR P35968 2/20 0.36
AURKB Q96GD4 2/20 0.36
DAPK3 O43293 2/20 0.36
PTK2 Q05397 2/20 0.36
JAK2 O60674 1/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
FYN P06241 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
PDGFRB P09619 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849950 0.95 GRK6 (0.42) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL3852023 0.90 GRK6 (0.42) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL5822082 0.89 GRK6 (0.42) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL5768922 0.84 GRK6 (0.41) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL3852749 0.81 GRK6 (0.41) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL343410 0.80 PAK4 (0.54) AURKAPAK4PLK4IGF1RFGFR1
SCHEMBL5823478 0.79 AURKA (0.40) GRK6AURKAPAK4PLK4IGF1R
SCHEMBL220647 0.77 PAK4 (0.57) AURKAPAK4PLK4IGF1RNTRK1
SCHEMBL19514407 0.76 IGF1R (0.40) AURKAPAK4PLK4IGF1RFGFR1
SCHEMBL3855238 0.75 AURKA (0.42) GRK6AURKAIGF1RFGFR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678169-A1 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Astrazeneca AB (SE) 2006-07-12 EP disclosed
WO-2005040159-A1 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2005-05-06 WO disclosed